News

Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results - ...
The Best Stock to Buy With Less Than $60 in the Market Sell-Off
One such example is Novo Nordisk (NYSE: NVO), the Denmark-based pharmaceutical leader whose shares are exchanging hands for ...
US Man Becomes Blind After Taking Ozempic Due to a Rare Eye Condition
An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.
24/7 Wall St.4d
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
The Local - Denmark3d
Denmark's Novo Nordisk sees shares tumble after competitor breakthrough
Shares in Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, ...
Lawsuit alleges Maryland man with diabetes became blind after taking Ozempic
A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...
ZAWYA1d
Novo Nordisk and Lifera sign MoU to enable the local production of semaglutide GLP-1 treatments in Saudi Arabia
The MOU marks a significant step in strengthening the Kingdom’s healthcare sector and pharmaceutical manufacturing ...
YourStory3d
Novo Nordisk’s India GCC steadily moves up the value chain
The global capability centre of Novo Nordisk in India is now closely engaged with the entire value chain of this global ...
Pharmabiz2d
Novo Nordisk clarifies Human Mixtard penfill to be replaced with injectables
Novo Nordisk clarifies Human Mixtard penfill to be replaced with injectables: Our Bureau, Bengaluru Wednesday, April 23, 2025, 13:30 Hrs [IST] Denmark-based global pharma major, N ...